Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients.

Taizen NakaseJunta MoroiTatsuya Ishikawa

Published in: Clinical and translational medicine (2018)

Even in acute ischemic stroke patients, both apixaban and dabigatran equally showed the anticoagulation activity. The reduction of inflammatory response might be prominent in apixaban, whereas the inhibition of platelet aggregation activity might be evident in dabigatran.

Keyphrases

atrial fibrillation
end stage renal disease
ejection fraction
oral anticoagulants
newly diagnosed
venous thromboembolism
prognostic factors
anti inflammatory
peritoneal dialysis
patient reported outcomes